A Case Report on Exercise and Type II Diabetes Mellitus: Can We Still Be Amazed?
DOI:
https://doi.org/10.17267/2238-2704rpf.v10i2.2795Keywords:
Metabolic Syndrome. Cardiac Rehabilitation. Blood Glucose. Quality of Life.Abstract
INTRODUCTION: Diabetes mellitus type 2 (DM2) is an independent risk factor for the development of cardiovascular diseases. Physical exercise is an adjuvant and effective therapy in the control of DM2, as it prevents functional decline, cardiovascular complications and improves quality of life. OBJECTIVE: To present the repercussions of a cardiovascular and metabolic rehabilitation program on glycemic control and functional capacity in a patient with DM2 and class II heart failure. METHODS: This is a case report that involved a 63-year-old woman, irregularly active, eutrophic, sarcopenic, hypertensive and with DM2 on insulin (NPH and ultra-fast) for 6 years, diagnosed with heart failure (HF) functional class II. Joins a supervised cardiovascular and metabolic rehabilitation program. Performs lipid profile, glycated hemoglobin, 6-minute walk test (6MWT), fasting glucose. During the session, capillary blood glucose, blood pressure (BP) and electrocardiographic tracing were monitored. The protocol consisted of stretching, neuromuscular exercises and a treadmill performed with a load of 12-14 on the Borg scale. The program lasted 16 weeks, being carried out twice a week totaling 80 min per session. RESULTS: There was an increase of 128.57% in the 6MWT (350 vs 800m). The glycated hemoglobin values before and after the training program were 12% -vs-7.5%; fasting blood glucose 346mg / dL-vs-105mg / dL; total cholesterol 158mg / dL-vs-108mg / dL; low-density lipoprotein (LDL) 95mg / dL-vs-58mg / dL; high density lipoprotein (HDL) 31mg / dL-vs-41mg / dL; triglycerides 115mg / dL-vs-97mg / dL and PA 185x95mmHg vs 139x85mmHg. At the end of the program, the use of subcutaneous insulin was withdrawn. CONCLUSION: The program proved to be adequate in improving submaximal functional capacity and in controlling plasma glycemic and lipid levels.